Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Verona Pharma plc (NASDAQ: VRNA)

 
VRNA Technical Analysis
5
As on 9th Jun 2023 VRNA STOCK Price closed @ 21.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.10 & Strong Buy for SHORT-TERM with Stoploss of 6.14 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VRNASTOCK Price

Open 21.11 Change Price %
High 21.50 1 Day 0.05 0.24
Low 20.71 1 Week -0.37 -1.72
Close 21.15 1 Month -0.21 -0.98
Volume 312060 1 Year 15.63 283.15
52 Week High 26.13 | 52 Week Low 3.55
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VRNA
Daily Charts		 VRNA
Intraday Charts		 Whats New @
Bazaartrend		 VRNA
Free Analysis
 
VRNA Important Levels Intraday
RESISTANCE22.67
RESISTANCE22.18
RESISTANCE21.88
RESISTANCE21.58
SUPPORT20.72
SUPPORT20.42
SUPPORT20.12
SUPPORT19.63
 
VRNA Forecast May 2024
Share
4th UP Forecast23.69
3rd UP Forecast22.88
2nd UP Forecast22.37
1st UP Forecast21.87
1st DOWN Forecast20.43
2nd DOWN Forecast19.93
3rd DOWN Forecast19.42
4th DOWN Forecast18.61
 
VRNA Weekly Forecast
4th UP Forecast22.61
3rd UP Forecast22.14
2nd UP Forecast21.85
1st UP Forecast21.56
1st DOWN Forecast20.74
2nd DOWN Forecast20.45
3rd DOWN Forecast20.16
4th DOWN Forecast19.69
 
VRNA Forecast2024
4th UP Forecast65.53
3rd UP Forecast51.3
2nd UP Forecast42.5
1st UP Forecast33.7
1st DOWN Forecast8.6
2nd DOWN Forecast-0.2
3rd DOWN Forecast-9
4th DOWN Forecast-23.23
 
 
VRNA Other Details
Segment EQ
Market Capital 304385056.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VRNA Address
VRNA
 
VRNA Latest News
 
Your Comments and Response on Verona Pharma plc
 
VRNA Business Profile
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 2 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. It also focuses on developing ensifentrine for the treatment of COVID-19. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom. Address: 3 More London Riverside, London, United Kingdom, SE1 2RE
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service